Mutation screening and burden analysis of GLT8D1 in Chinese patients with amyotrophic lateral sclerosis

Bei Cao,Xiaojing Gu,Qianqian Wei,Chunyu Li,Yongping Chen,Ruwei Ou,Yanbing Hou,Lingyu Zhang,Tao Li,Wei Song,Bi Zhao,Ying Wu,Xueping Chen,Huifang Shang
DOI: https://doi.org/10.1016/j.neurobiolaging.2020.10.017
IF: 5.133
2021-05-01
Neurobiology of Aging
Abstract:<p>The glycosyltransfersase 8 domain containing 1 (<em>GLT8D1</em>) gene was identified to be an amyotrophic lateral sclerosis (ALS) causative gene via pedigree co-segregation and burden analysis. In the current study, 977 Chinese sporadic ALS (sALS) cases and 47 Chinese familial ALS (fALS) cases underwent whole exome sequencing. Rare variants with MAF&lt;0.1% in <em>GLT8D1</em> were analyzed. One likely pathogenic variant in the exon 4 was identified in a fALS case and validated within the family. Moreover, 3 rare variants of uncertain significance (VUS) in 4 sALS patients and 1 rare VUS in 1 fALS patient were also identified. Furthermore, by using the East Asian controls from the gnomAD database, there was no significant enrichment of rare variants of <em>GLT8D1</em> at the whole gene level or the exon 4-specific level in Chinese sALS patients. In conclusion, co-segregation findings further support the pathogenic role of <em>GLT8D1</em> in fALS. However, no pathogenic mutation and no enrichment of rare variants were found in sALS patients, which implies that <em>GLT8D1</em> may not play a role in Chinese patients with sALS.</p>
neurosciences,geriatrics & gerontology,gerontology
What problem does this paper attempt to address?